溶栓治疗后脑卒中患者应用他汀类药物疗效分析被引量：1

The curative effects of statin on stroke patient with thrombolysis treatment

下载PDF

导出

摘要目的:探讨在脑卒中患者经溶栓治疗后,他汀类药物的应用问题及其疗效。方法:服用或未服用他汀类药物的经溶栓治疗后脑卒中患者共9例,根据美国国立卫生院卒中量表(NIHSS)及改良Rankin评分(modified Rankin scale,mRS)评分来评价患者不同时期的脑功能恢复情况。结果:脑卒中急性期服用他汀者发病48 h NIHSS评分下降较未用他汀者明显(P<0.01),发病3个月mRS评分0～2分者4例,无病死病例(P<0.01)。结论:在接受溶栓治疗的脑卒中患者中,他汀类药物在急性期的应用可促进发病后脑功能的恢复。 Objective：To assess the curative effects of statin drugs on stroke patient with thrombolysis treatment.Methods：Brain function recovery condition of 9 stroke cases with thrombolysis treatment taking or no-taking statin was evaluated during different periods according to Modified Rankin scale（mRS） and Nationel Institutes of Health Stroke scale（NIHSS）.Results：The NIHSS scores of cases who took statin were significantly lower than that of no-taking statin at 48 hours（P〈0.01）.There were 4 cases′ mRS scores between 0-2 and no death with 3 months statin treatment.Conclusions：statin treatment can promote brain function recovery of stroke patient with thrombolysis treatment.

作者韦宁欧世宁韦英海黎彬如

机构地区广西民族医院神经内科

出处《蚌埠医学院学报》 CAS 2012年第4期431-432,共2页 Journal of Bengbu Medical College

关键词脑血管意外溶栓治疗他汀类药物 cerebral vascular accident thrombolysis treatment statin

分类号 R743.3 [医药卫生—神经病学与精神病学]

引文网络
相关文献

参考文献10

1Montaner J,Chacon P,Krupinski J,et al.Simvastatin in the acutephase of ischemic stroke:a safety and efficacy pilot trial[J].EurJ Neurol,2008,15(1):82-90.
2Lakhan S E,Bagchi S,Hofer M.Statins and clinical outcome ofacute ischemic stroke:a systematic review[J].Int Arch Med,2010,3:22.
3Alvarez-Sabin J,Huertas R,Quintana M,et al.Prior statin usemay be associated with improved stroke outcome after tissueplasminogen activator[J].Stroke,2007,38(3):1076-1078.
4Uyttenboogaart M,Koch MW,Koopman K,et al.Lipid profile,statin use,and outcome after intravenous thrombolysis for acuteischaemic stroke[J].J Neurol,2008,255(6):875-880.
5Meier N,Nedeltchev K,Brekenfeld C,et al.Prior statin use,intracranial hemorrhage,and outcome after intra-arterialthrombolysis for acute ischemic stroke[J].Stroke,2009,40(5):1729-1737.
6Prinz V,Endres M.The acute(cerebro)vascular effects of statins[J].Anesth Analg,2009,109(2):572-584.
7Bourcier T,Libby P.HMG CoA reductase inhibitors reduceplasminogen activator inhibitor-1 expression by human vascularsmooth muscle and endothelial cells[J].Arterioscler ThrombVasc Biol,2000,20(2):556-562.
8Notarbartolo A,Davi G,Averna M,et al.Inhibition of thromboxanebiosynthesis and platelet function by simvastatin in type IIahypercholesterolemia[J].Arterioscler Thromb Vasc Biol,1995,15(2):247-251.
9Sanguigni V,Pignatelli P,Lenti L,et al.Short-term treatment withatorvastatin reduces platelet CD40 ligand and thrombin generationin hypercholesterolemic patients[J].Circulation,2005,111(4):412-419.
10Zhang L,Zhang ZG,Ding GL,et al.Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant humantissue-type plasminogen activator in the rat[J].Circulation,2005,112(22):3486-3494.